ADVANCED SENSING SOLUTIONS FOR A HEALTHIER AND SAFER WORLD.
Our product portfolio delivers authentication, product viability assurance, and pathogen detection to reduce loss and harm for our customers. Founded in 2013 as an MIT “Tough Tech” spinout, we have proven commercial solutions to help with some of the world’s toughest challenges.
Safar Partners, The MIT Engine and Moore Capital Ventures along with a number of other visionary professional and private investors have been strong and active supporters of our growth. Whether it’s revolutionizing the way consumers interact with products, measuring the quality of the air around us, preventing accidental use of counterfeit pharmaceuticals, or enabling the shift to telemedicine and workplace testing during the recent COVID-19 crisis, C2Sense is well-positioned to lead the next generation of sensor development and innovation.
C2Sense is committed to providing a website that is accessible to the widest possible audience, regardless of circumstance and ability. We aim to adhere as closely as possible to the Web Content Accessibility Guidelines (WCAG 2.0, Level AA), published by the World Wide Web Consortium (W3C). These guidelines explain how to make Web content more accessible for people with disabilities. Conformance with these guidelines will help make the web more user friendly to everyone. Whilst C2Sense strives to adhere to the guidelines and standards for accessibility, it is not always possible to do so in all areas of the website and we are currently working to achieve this. Be aware that due to the dynamic nature of the website, minor issues may occasionally occur as it is updated regularly. We are continually seeking out solutions that will bring all areas of the site up to the same level of overall web accessibility.
If you have any comments and or suggestions relating to improving the accessibility of our site, please don't hesitate to contact us. Your feedback will help us make improvements.